Livofly is the best liver tonic in Indiathat helps cure all liver problems. It aids improve metabolism, works as a mild laxative and helps control hyperacidity. It is also available in SUGAR FREE variant and works as an effective ayurvedic medicine for fatty liver& cirrhosis.
Triphala (Emblica officinalis, Terminaliabelerica, and Terminaliachebula), Guduchi (Tinosporacordifolia), Kutaki (Picrorhizakurroa), Kalmegha (Andrographispaniculata), Vasa (Adhatodavasica), Amalaki (Emblica officinalis), Bibhitaki (Terminalia belerica), Haritaki (Terminalia chebula), Nimba (Azadirachtaindica), Kakmachi (Solanumnigrum), Bhumyamlaki (Phyllanthus niruri), Bhringraj (Eclipta alba), Peetpapra (Fumaria parviflora), Vidanga (Embeliaribes), Sarpunkha (Tephrosiapurpurea), andMuli (Raphanus sativus)
LIVOFLY acts as an Ayurvedic medicine for liver that helps keep the liver healthy by improving all body metabolisms. It works as a mild laxative and aids with hyperacidity. The best liver syrup in India allows for a gradual detoxification of liver & kidneys by promoting a comprehensive elimination of toxins from the body. It stimulates secretion of the bile from the liver and exerts laxative & carminative effects.
Packed in light resistant Amber coloured PET Bottle with pilfer proof ROPP Cap (made of aluminium & internationally accepted).
Net content: 200 ml
Our liver supplement is manufactured in WHO GMP certified plant and made using 100% natural ingredients.
Benefits of Livofly
It helps with hyperacidity.
It aids in keeping the liver healthy.
It helps improve digestion & all body metabolisms.
It helps promote the elimination of toxins from the body.
It helps stimulate the secretion of bile from the liver and exerts laxative & carminative effects.
It works as a mild laxative.
It helps in proper functioning of liver.
It aids in the recovery process from Hepatitis A and B, drug and alcohol addiction, the after-effects of chemotherapy and a lethargic liver.
It acts as a laxative, stomachic, anthelmintic, cardiotonic and antipyretic.
The plant of Kutaki contains major bioactive compounds, such asAspicroside-I, II, III and Kutkoside and a bitter glycosidal principle, Kutkin.
It helps protects liver cells from toxins.
It significantly helps reduce the levels of serumSGPT and SGOT.
It aids increase the total protein and albumin/globulin ratio level.
Kalmegha (Andrographis paniculata)
It shows benefits against liver damage caused by agents with different hepatotoxic mechanisms.
It has antipyretic (lowers fevers), anti-inflammatory, antibacterial, antioxidant, antiparasitic and hepatoprotective (liver protecting) activities.
|Amalaki (Emblicaofficinalis) *Fr.||350mg|
|Bibhitaki (Terminalia belerica) *Fr.||350mg|
|Haritaki (Terminalia chebula) *Fr.||350mg|
|Vasa (Adhatodavasica) *Lf.||175mg|
|Kalmegha(Andrographis paniculata) *A.Pt.||175mg|
|Nimba (Azadirachtaindica) *St. Bk.||175mg|
|Kutaki (Picrorhizakurroa) *Rz. & Rt.||175mg|
|Kakmachi (Solanum nigrum) *W.P.||175mg|
|Bhumyamlaki (Phyllanthus niruri) *W.P.||350mg|
|Bhringraj (Eclipta alba) *W.P.||350mg|
|Peetpapra (Fumaria parviflora) *W.P.||350mg|
|Vidanga (Embeliaribes) *Fr.||350mg|
|Sarpunkha (Tephrosiapurpurea) *W.P.||350mg|
|Muli (Raphanussativus) *Sd.||175mg|
Dosage & Storage
Adult: 1-2 teaspoonful twice a day before meal.
Children: 0.5-1 teaspoonful twice a day before meal.
Continue the treatment for 1-3 months till complete relief or as directed by the physician.
Store in a cool dry place, away from direct sunlight.
No side effects like jaundice, stomach upsets, or fluid accumulations (generally seen with modern medicines) are observed with Livofly.
Safety Description of Preclinical study for Product efficacy
Livofly treatment showed a dose dependent effect on improving liver function parameter specially ALT and AST in Paracetamol induced hepatotoxicity in Wistar rats.
Description of Preclinical study for Product Safety
It was found to be safe in both acute (single dose administration) and repeated dose (28 days administration) toxicity studies.
These preclinical studies show Livofly to be devoid of clinically significant adverse effects.